Antidote Technologies
PrivateLast Round
Series C
Jun 3, 2021
Total Funding Raised
$41M
Company Overview
Antidote Technologies is a digital health company that provides a patient recruitment and matching platform to connect individuals with clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antidote Technologies Comparables
Compare Antidote Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Patiro | 86% | |
| AutoCruitment | 86% | |
| Carebox Healthcare Solutions | 86% |
Antidote Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 3, 2021 | ||||
| VC Round | Sep 7, 2017 | ||||
| Series B | Feb 5, 2015 | ||||
| Series A | May 8, 2013 | ||||
| Seed | Oct 27, 2011 |
Antidote Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Series B, Series A, Seed |
| Smedvig Capital | Series C, VC Round, Series B |
| LBO France | Series C |
| Octopus Investments | Series B, Series A |
| Octopus Ventures | Series C, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2017
$11M round led by Merck & Co., Inc.
- Feb 5, 2015
$14M round led by Smedvig Capital.
Antidote Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Antidote Technologies's valuation, stock price, and market status.
Is Antidote Technologies a public or private company?
Antidote Technologies is a private company.
What is the current stock price of Antidote Technologies?
Antidote Technologies is a private company with no public stock price. No recent secondary market data is available.
How much is Antidote Technologies worth (valuation)?
Valuation information for Antidote Technologies is not publicly available.
Can I buy Antidote Technologies stock?
Antidote Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Antidote Technologies's last funding round?
Antidote Technologies's most recent funding round was Series C on June 3, 2021.
Who are the main investors in Antidote Technologies?
Key investors in Antidote Technologies include Amadeus Capital Partners, Smedvig Capital, LBO France, Octopus Investments.
Will Antidote Technologies IPO soon?
No public IPO plans have been announced for Antidote Technologies.
How can I track Antidote Technologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Antidote Technologies's secondary market activity and sign up for updates.